Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 19 November, 2009 and appeared in  Issue 496DietCulturally Aware Care

Fasting Not Required for Cholesterol Test

Patients do not need to fast before having their cholesterol tested, a major study has found. 

Advertisement

Cholesterol tests are used as a key part of assessing a patient's risk of cardiovascular problems. Fasting has been recommended as it had been thought the body needed enough time to digest food in the system and to clear any fatty particles from the blood. This was in order to produce an accurate reading of so-called "bad" cholesterol -- or low-density lipoprotein (LDL).

However, Naveed Sattar, Professor of Metabolic Medicine and Chris Packard, an Honorary Professor in Developmental Medicine, both of the University of Glasgow, together with researchers from the University of Cambridge, found that test results were just as accurate without fasting.

"After analysing data from 300,000 patients, the results were just as accurate if the patient had eaten before the test," said Professor Sattar.

Lead researcher John Danesh, Professor of Epidemiology and Medicine at the University of Cambridge, continued, "For decades, people have been asked to fast overnight before their cholesterol tests. Our findings indicate that cholesterol measurements are at least as good -- and probably somewhat better -- when made without fasting."

The study also adds to the ongoing controversy over whether testing for blood proteins called apolipoproteins is a more reliable way of predicting heart risk than cholesterol testing.

"The studies showed that analyzing "good" cholesterol -- or high-density lipoprotein (HDL) in conjunction with LDL was just as informative as testing for apolipoproteins AI and B. Furthermore our paper shows that once "bad" cholesterol and "good" HDL-cholesterol are known, using the levels of triglycerides or fat in the blood, as a means to predict the risk of heart disease, is unhelpful," said Professor Sattar.

Professor Peter Weissberg, Medical Director of the British Heart Foundation, which funded the study, said, "Given the pressure the NHS is under, it is good news that doctors don't need to spend money on setting up more sophisticated tests based on apolipoproteins. But the study underlines the importance of all GP's being able to measure HDL cholesterol as well as total cholesterol in order to make the best predictions about heart disease risk."

The Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302: 1993-2000

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 19 November, 2009 and appeared in  Issue 496DietCulturally Aware Care

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

2012 Most Popular Articles:

ADA/EASD Issue New Hyperglycemia Management Guidelines
Posted April 26, 2012
Type 2 More Dangerous in Children
Posted May 03, 2012
It’s the Variety of Fruit-and-Veggie That Lower Diabetes Risk
Posted May 03, 2012
Questioning Carbohydrate Restriction in Diabetes Management
Posted May 18, 2012
Ultra-Long-Acting Insulin Degludec, Two New Studies
Posted April 26, 2012
Eating Low Glycemic Index Foods at Breakfast Can Control Blood Sugar throughout the Day
Posted April 18, 2012
Metformin May Treat a Leading Cause of Blindness
Posted May 10, 2012
A Candy Treatment that Fights Diabetes and May Replace TZD's?
Posted May 10, 2012
Metformin May Not Be the Golden Pill After All for Treating Type 2 Diabetes
Posted April 18, 2012
Doubts Over Long Term Effectiveness of Group Education for Diabetes Patients
Posted May 03, 2012

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control